Immunolabeling confirmed the enhancement of iNOS, GBP2, and C3 proteins in astrocytes surrounding parenchymal amyloid plaques in the TgF344-AD model, which are primarily composed of Aβ42 (Figure 6). This evidence concerns the gene NOS2 and Alzheimer disease.